Group 1 - The core point of the article is that Hanbang Technology (SH 688755) held its 22nd meeting of the first board of directors on August 25, 2025, where it reviewed proposals including the nomination of independent director candidates for the second board [1] - For the first half of 2025, Hanbang Technology's revenue composition was as follows: small molecule drug separation and purification equipment accounted for 70.99%, large molecule drug separation and purification equipment accounted for 22.94%, and others accounted for 6.07% [1] - As of the report date, Hanbang Technology's market capitalization was 4.8 billion yuan [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to rising stock prices among industry-listed companies [1]
汉邦科技：8月25日召开董事会会议